Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Heptares Therapeutics

Heptares Therapeutics
2007 FOUNDED
M&A STATUS
71-80 EMPLOYEES
Grant LATEST DEAL TYPE
5 FINANCING ROUNDS
1 INVESTMENTS
Description

Provider of drug candidates in multiple disease areas. The company has developed a proprietary technology for making purified, stabilized and functional G-protein-coupled receptors (GPCRs ), overcoming a major limiting factor to the development of new drugs targeting this group. It also designs and develops drugs to tackle diseases involving the nervous system and metabolism.

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Parent Company
Primary Office
  • Granta Park
  • Great Abington
  • Cambridge CB21 6GP
  • England, United Kingdom

Heptares Therapeutics Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Heptares Therapeutics‘s full profile, request access.

Request full access to PitchBook

Heptares Therapeutics Competitors (67)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Ra Pharmaceuticals Formerly VC-backed Cambridge, MA 00 00000 000000&0 00000
0000000000000 Corporate Backed or Acquired Sunnyvale, CA 0000 000.00 000000&0 000.00
00000000 00000000 Corporate Backed or Acquired Boston, MA 0 00.000 000000000 00.000
00000000 000000000 Formerly VC-backed Carmiel, Israel 000 000.00 00000000000 000.00
000000 Corporate Backed or Acquired Wilmington, DE 0000 00000000000
To view this company’s complete list of competitors, request access »

Heptares Therapeutics Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000000 000000 30-Nov-2016 000000000000000000 0000 Biotechnology 00000 00000000 00.0
To view this company’s complete investment and acquisition history, request access »

Heptares Therapeutics Subsidiaries (1)

Company Name Industry Location Founded
00000000 000000 Biotechnology Zürich, Switzerland
To view this company’s complete subsidiary history, request access »

Heptares Therapeutics Former Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Heptares Therapeutics‘s full profile, request access.

Request full access to PitchBook

Heptares Therapeutics Executive Team (16)

Name Title Board
Seat
Contact
Info
Malcolm Weir Ph.D Chief Executive Officer, Chief Research & Development Officer, Board Member & Co-Founder
Daniel Grau President
Andrew Doré Ph.D Director
Barry Kenny Ph.D Chief Business Officer
Chris Tate Ph.D Co-Founder & Advisor

2 Former Executives

You’re viewing 5 of 16 executives. Get the full list »

Heptares Therapeutics Board Members (8)

Name Representing Role Since Contact
Info
0000 00000 00 Self Director 000 0000

7 Former Board Members

You’re viewing 1 of 8 board members. Get the full list »